Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00350909 · ClinicalTrials.gov registry record · Phase 2
Brief Intervention for Drug Abusing Adolescents
A Phase 2 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 2
- Development phase
- 160
- Enrollment target
NCT00350909 is a Phase 2 study that has completed, run by University of Minnesota. The registered enrollment target is 160 participants.
The verdict
NCT00350909, a Phase 2 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 160 participants
- Enrollment target
Study Summary
The purpose of this clinical trail is to evaluate the efficacy of a brief, cognitive-behavioral therapeutic intervention for adolescents reporting mild or moderate drug abuse (MMDA). This school-based initiative employs a collaborative effort between the University of Minnesota researchers and the St. Paul Public Schools. This intervention aims to reduce post-treatment drug use behaviors and enhance drug-use resistant cognitions and problem-solving skills.
Interventions
- BEHAVIORAL brief intervention (cognitive-behavioral therapy)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2005-09 |
| Est. Completion | 2008-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00350909
The ClinicalTrials.gov registry entry for NCT00350909 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which brief intervention (cognitive-behavioral therapy) is the first listed.
NCT00350909 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00350909 about?
NCT00350909 is a clinical study titled "Brief Intervention for Drug Abusing Adolescents". The purpose of this clinical trail is to evaluate the efficacy of a brief, cognitive-behavioral therapeutic intervention for adolescents reporting mild or moderate drug abuse (MMDA). This school-based initiative employs a collaborative effort between the University of Minnesota researchers and the S...
What is the current status of trial NCT00350909?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 160 participants. The study started on 2005-09. Estimated completion is 2008-07.
What interventions are being tested in trial NCT00350909?
The interventions under investigation include: brief intervention (cognitive-behavioral therapy) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00350909?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.